Should we be using comprehensive panels when testing for hereditary cancer syndromes?
There are many options to choose from, including large gene panels with up to 80 genes at the same cost as BRCA 1/2 testing, while others offer just 4-5 extra genes that are included in the NCCN guidelines.
Answer from: Medical Oncologist at Academic Institution
I think the days of single gene testing are limited. Certainly if a deleterious gene has already been identified, family members only need to be tested for that mutation. In rare circumstances when there is a large family with a substantial cancer history that perfectly replicates a known syndrome, ...